M. Tenforde

发表

Maternal Hepatitis B Infection and Pregnancy Outcomes in the United States: A Population-Based Cohort Study

R. Heffron, S. Hawes, K. Bajema, 2018, Open forum infectious diseases.

Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.

Manish M Patel, A. Randolph, J. Newburger, 2021, JAMA.

Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome.

Manish M Patel, A. Randolph, M. Son, 2021, JAMA neurology.

Modulating host immune responses to fight invasive fungal infections.

J. Jarvis, J. Scriven, S. Levitz, 2017, Current opinion in microbiology.

Modeling clinical trajectory status of critically ill COVID-19 patients over time: A method for analyzing discrete longitudinal and ordinal outcomes

M. Exline, Akram Khan, W. Self, 2022, Journal of Clinical and Translational Science.

Cost-effectiveness of cryptococcal antigen screening at CD4 counts of 101–200 cells/µL in Botswana

J. Jarvis, M. Mine, T. Chiller, 2021, Wellcome open research.

Update: Characteristics of Patients in a National Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injuries — United States, October 2019

Brian A. King, Emily N. Ussery, Janet J. Hamilton, 2019, MMWR. Morbidity and mortality weekly report.

E-cigarette Product Use, or Vaping, Among Persons with Associated Lung Injury — Illinois and Wisconsin, April–September 2019

K. O'Laughlin, J. Layden, J. Chevinsky, 2019, MMWR. Morbidity and mortality weekly report.

Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Preliminary Report.

Brian A. King, J. Layden, J. Kanne, 2020, The New England journal of medicine.

Serial Thromboelastography and the Development of Venous Thromboembolism in Critically Ill Patients With COVID-19

W. Self, T. Rice, C. Lindsell, 2022, Critical care explorations.

Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19—Nashville, Tennessee

Manish M Patel, W. Self, T. Rice, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Associations between persistent symptoms after mild COVID‐19 and long‐term health status, quality of life, and psychological distress

Akram Khan, W. Self, T. Rice, 2022, Influenza and other respiratory viruses.

Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana

R. Hayes, J. Jarvis, M. Mine, 2020, HIV medicine.

Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus–associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial

S. Jaffar, J. Changalucha, J. Jarvis, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

India Ink Stain and Cryptococcal Antigen Test for Cryptococcal Infection

J. Jarvis, M. Tenforde, H. K. Mitchell, 2019, Revolutionizing Tropical Medicine.

Rapid antiretroviral therapy initiation in low- and middle-income countries: A resource-based approach

A. Walker, D. Gibb, Y. Manabe, 2019, PLoS medicine.

Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort Study

D. Dowdy, R. Shivakoti, T. Campbell, 2017, Journal of acquired immune deficiency syndromes.

Immune correlates of HIV-associated cryptococcal meningitis

J. Jarvis, T. Harrison, J. Scriven, 2017, PLoS pathogens.

Preventing Cryptococcosis—Shifting the Paradigm in the Era of Highly Active Antiretroviral Therapy

J. Jarvis, R. Rajasingham, D. Meya, 2015, Current Tropical Medicine Reports.

Causes of Pediatric Meningitis in Botswana: Results From a 16-Year National Meningitis Audit.

A. Steenhoff, J. Jarvis, M. Mine, 2019, The Pediatric infectious disease journal.

Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness among Adults in the United States, 2019-2020: A test-negative study.

Samuel M. Brown, Manish M Patel, M. Exline, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

M. Exline, Akram Khan, W. Self, 2022, BMJ.

The prevalence of laboratory-confirmed Pneumocystis jirovecii in HIV-infected adults in Africa: A systematic review and meta-analysis.

J. Jarvis, M. Tenforde, David S. Lawrence, 2021, Medical mycology.

Treatment for HIV‐associated cryptococcal meningitis

N. Ford, Tianjing Li, J. Jarvis, 2018, The Cochrane database of systematic reviews.

Point Prevalence Estimates of Activity-Limiting Long-Term Symptoms among U.S. Adults ≥1 Month After Reported SARS-CoV-2 Infection, November 1, 2021

S. Saydah, A. Iuliano, B. Cadwell, 2022, The Journal of infectious diseases.

Symptoms and recovery among adult outpatients with and without COVID‐19 at 11 healthcare facilities—July 2020, United States

Samuel M. Brown, Manish M Patel, M. Exline, 2020, Influenza and other respiratory viruses.

BNT162b2 Protection against the Omicron Variant in Children and Adolescents

Manish M Patel, A. Randolph, M. Cameron, 2022, The New England journal of medicine.

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021

David W. McDonald, Meghan A. Wallace, Joel D. Levitt, 2021, MMWR. Morbidity and mortality weekly report.

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021

Samuel M. Brown, Manish M Patel, M. Exline, 2021, MMWR. Morbidity and mortality weekly report.

Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines

Manish M Patel, M. Exline, W. Self, 2021, Nature Communications.

Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐ and Delta‐Related outpatient illness among adults, October 2021–February 2022

A. Monto, B. Flannery, E. Belongia, 2022, medRxiv.

Vitamin D status and risk of incident tuberculosis disease: a systematic review and individual participant data meta-analysis

W. Fawzi, G. Montepiedra, S. Spector, 2018, bioRxiv.

Influenza vaccine effectiveness against hospitalization in the United States, 2019-2020.

Manish M Patel, J. D. da Silva, A. Monto, 2020, The Journal of infectious diseases.

Effect of antigenic drift on influenza vaccine effectiveness in the United States - 2019-2020.

Manish M Patel, A. Monto, B. Flannery, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States

M. Exline, Akram Khan, W. Self, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Thromboelastography Parameters and Platelet Count on Admission to the ICU and the Development of Venous Thromboembolism in Patients With Coronavirus Disease 2019

Manish M Patel, W. Self, T. Rice, 2021, Critical care explorations.

Prevalence and Sequelae of Cryptococcal Antigenemia in Antiretroviral Therapy-experienced Populations: An Evaluation of Reflex Cryptococcal Antigen Screening in Botswana.

J. Jarvis, M. Mine, M. Molefi, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study

M. Exline, Akram Khan, W. Self, 2022, BMJ.

C-Reactive Protein (CRP), Interferon Gamma-Inducible Protein 10 (IP-10), and Lipopolysaccharide (LPS) Are Associated with Risk of Tuberculosis after Initiation of Antiretroviral Therapy in Resource-Limited Settings

R. Bollinger, D. Dowdy, D. Asmuth, 2015, PloS one.

Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network — 12 States, April–August 2020

Samuel M. Brown, Manish M Patel, M. Exline, 2020, MMWR. Morbidity and mortality weekly report.

Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis

W. Fawzi, G. Montepiedra, S. Spector, 2019, PLoS medicine.

High Mortality in HIV-Associated Cryptococcal Meningitis Patients Treated With Amphotericin B–Based Therapy Under Routine Care Conditions in Africa

J. Jarvis, M. Molefi, M. Tenforde, 2018, Open forum infectious diseases.

[Accepted Manuscript] Short Course High-dose Liposomal Amphotericin B for HIV-associated Cryptococcal Meningitis: A phase-II Randomized Controlled Trial.

S. Jaffar, J. Changalucha, J. Jarvis, 2018 .

Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021

David W. McDonald, Meghan A. Wallace, Joel D. Levitt, 2021, MMWR. Morbidity and mortality weekly report.

Early season pediatric influenza B/Victoria virus infections associated with a recently emerged virus subclade — Louisiana, 2019

L. Brammer, J. Hand, Theresa M Sokol, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Early Season Pediatric Influenza B/Victoria Virus Infections Associated with a Recently Emerged Virus Subclade — Louisiana, 2019

L. Brammer, J. Hand, Theresa M Sokol, 2020, MMWR. Morbidity and mortality weekly report.

A new point-of-care test to diagnose tuberculosis

J. Jarvis, M. Tenforde, 2019 .

mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients

M. Exline, Akram Khan, W. Self, 2022, The Journal of infectious diseases.

Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022

William F. Fadel, S. E. Reese, C. Mcevoy, 2022, MMWR. Morbidity and mortality weekly report.

Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022

M. Exline, Akram Khan, W. Self, 2022, MMWR. Morbidity and mortality weekly report.

Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021

Manish M Patel, M. Exline, Akram Khan, 2022, MMWR. Morbidity and mortality weekly report.

Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022

William F. Fadel, S. E. Reese, C. Mcevoy, 2022, MMWR. Morbidity and mortality weekly report.

Theoretical framework for retrospective studies of the effectiveness of SARS-CoV-2 vaccines

N. Jewell, B. Cowling, N. Dean, 2021, medRxiv.

Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020

M. Cetron, L. Rotz, M. Killerby, 2020, Emerging infectious diseases.

Telework Before Illness Onset Among Symptomatic Adults Aged ≥18 Years With and Without COVID-19 in 11 Outpatient Health Care Facilities — United States, July 2020

Samuel M. Brown, Manish M Patel, M. Exline, 2020, MMWR. Morbidity and mortality weekly report.

Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal Meningitis

A. Steenhoff, Hunter H. Stone, J. Jarvis, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and clinical response of intraventricular caspofungin for Scedosporium apiospermum complex central nervous system infection

A. Ko, S. Graham, M. Tenforde, 2016, Medical mycology case reports.

Epidemiology of adult meningitis during antiretroviral therapy scale-up in southern Africa: Results from the Botswana National Meningitis Survey.

A. Steenhoff, J. Jarvis, M. Mine, 2019, The Journal of infection.

Mortality from HIV‐associated meningitis in sub‐Saharan Africa: a systematic review and meta‐analysis

J. Jarvis, A. Gertz, C. Farquhar, 2020, Journal of the International AIDS Society.

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

Simon Li, Vinod Havalad, Manish M Patel, 2020, The New England journal of medicine.

Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-C.

A. Randolph, N. Cvijanovich, S. Schwartz, 2022, Pediatrics.

Cost-effectiveness of cryptococcal antigen screening at CD4 counts of 101-200 cells/µL in Botswana.

J. Jarvis, M. Mine, T. Chiller, 2021, Wellcome open research.

Outcomes of reflex cryptococcal antigen (CrAg) screening in HIV-positive patients with CD4 counts of 100-200 cells/µL in Botswana.

J. Jarvis, M. Mine, T. Chiller, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low-cerebrospinal fluid white cell counts and mortality in HIV-associated pneumococcal meningitis.

J. Jarvis, G. Meintjes, T. Harrison, 2019, AIDS.

Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States

Samuel M. Brown, Manish M Patel, H. Gershengorn, 2021, medRxiv.

Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020

Jay S. Steingrub, Todd W. Rice, Manish M. Patel, 2020, MMWR. Morbidity and mortality weekly report.

Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults ≥18 Years in 11 Outpatient Health Care Facilities — United States, July 2020

Samuel M Brown, Todd W Rice, Samuel M. Brown, 2020, MMWR. Morbidity and mortality weekly report.

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.

M. Exline, Akram Khan, W. Self, 2021, JAMA.

Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network — 13 Academic Medical Centers, April–June 2020

Samuel M. Brown, Manish M Patel, M. Exline, 2020, MMWR. Morbidity and mortality weekly report.

Mortality in adult patients with culture-positive and culture-negative meningitis in the Botswana national meningitis survey: a prevalent cohort study

J. Jarvis, M. Mine, T. Masupe, 2019, The Lancet. Infectious diseases.

Neurological Sequelae of Adult Meningitis in Africa: A Systematic Literature Review

J. Jarvis, M. Tenforde, H. K. Mitchell, 2017, Open forum infectious diseases.

Human Herpesvirus-6 Detection in Cerebrospinal Fluid on the BioFire FilmArray Meningitis/Encephalitis Panel in a High Human Immunodeficiency Virus-Prevalence African Setting

J. Jarvis, M. Mine, M. Tenforde, 2022, Open forum infectious diseases.

Laboratory Evaluation of the VISITECT Advanced Disease Semiquantitative Point-of-Care CD4 Test

J. Jarvis, M. Mine, M. Tenforde, 2022, Journal of acquired immune deficiency syndromes.

Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in Botswana

J. Jarvis, M. Mine, T. Chiller, 2019, Wellcome open research.

HIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited Settings

J. Jarvis, M. Tenforde, T. Leeme, 2016, Current Clinical Microbiology Reports.

The Association Between Personal Health Record Use and Diabetes Quality Measures

John Hickner, Anil Jain, A. Nowacki, 2012, Journal of General Internal Medicine.

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022

S. E. Reese, C. Mcevoy, R. Link-Gelles, 2022, MMWR. Morbidity and mortality weekly report.

Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection

M. Exline, W. Self, N. Shapiro, 2022, The Journal of clinical investigation.

Identifying COVID-19 Risk Through Observational Studies to Inform Control Measures.

Manish M Patel, M. Tenforde, Kiva A Fisher, 2021, JAMA.

Ascertainment of vaccination status by self‐report versus source documentation: Impact on measuring COVID‐19 vaccine effectiveness

M. Exline, W. Self, A. Ginde, 2022, Influenza and other respiratory viruses.

A literature review of severity scores for adults with influenza or community-acquired pneumonia – implications for influenza vaccines and therapeutics

Manish M Patel, W. Self, E. Chow, 2021, Human vaccines & immunotherapeutics.

Differentiating severe and non-severe lower respiratory tract illness in patients hospitalized with influenza: Development of the Influenza Disease Evaluation and Assessment of Severity (IDEAS) scale

Manish M Patel, J. Ramirez, M. Rolfes, 2021, PloS one.

Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States

Samuel M. Brown, Manish M Patel, H. Gershengorn, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Characteristics of Adult Outpatients and Inpatients with COVID-19 — 11 Academic Medical Centers, United States, March–May 2020

Manish M Patel, M. Exline, Akram Khan, 2020, MMWR. Morbidity and mortality weekly report.

Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States

Manish M Patel, H. Gershengorn, M. Exline, 2021, Clinical Infectious Diseases.

Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.

M. Exline, Akram Khan, W. Self, 2022, MMWR. Morbidity and mortality weekly report.

Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescents

K. Mandl, A. Randolph, J. Newburger, 2021, EClinicalMedicine.

Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study

A. Monto, D. Hager, N. Shapiro, 2022, medRxiv.

Long-term Protection Associated With COVID-19 Vaccination and Prior Infection.

R. Link-Gelles, M. Tenforde, M. Patel, 2022, Journal of the American Medical Association (JAMA).

Protection of 2 and 3 mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized with COVID-19 - VISION Network, August 2021 - March 2022.

S. E. Reese, C. Mcevoy, P. Embí, 2022, The Journal of infectious diseases.

Influenza vaccine effectiveness in inpatient and outpatient settings in the United States, 2015 - 2018.

Manish M Patel, A. Monto, B. Flannery, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Multisystem Inflammatory Syndrome in Adults

M. Tenforde, S. Morris, Sapna Bamrah Morris, 2020, Chest.

Evaluation of a Novel Semiquantitative Cryptococcal Antigen Lateral Flow Assay in Patients with Advanced HIV Disease

J. Jarvis, T. Harrison, N. Govender, 2020, Journal of Clinical Microbiology.

Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods

William F. Fadel, S. E. Reese, C. Mcevoy, 2023, JAMA network open.

Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)—United States, March–June and October–December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes

Samuel M. Brown, Manish M Patel, M. Exline, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

An updated systematic review of HIV‐associated cryptococcal meningitis treatment strategies

N. Ford, T. Chiller, R. Rajasingham, 2022, HIV medicine.

ICU Bed Utilization During the Coronavirus Disease 2019 Pandemic in a Multistate Analysis—March to June 2020

Samuel M. Brown, Manish M Patel, M. Exline, 2021, Critical care explorations.

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022

M. Exline, Akram Khan, W. Self, 2022, Open forum infectious diseases.

Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States

M. Exline, Akram Khan, W. Self, 2022, Vaccine.

Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February–May 2021

Manish M Patel, S. Schrag, A. Monto, 2021, The Journal of infectious diseases.

mRNA Vaccine Effectiveness against COVID-19 among Symptomatic Outpatients Aged >=16 Years in the United States, February to May 2021

S. Schrag, A. Monto, G. Balasubramani, 2021, medRxiv.

Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease

J. Jarvis, T. Harrison, N. Govender, 2020, Journal of Clinical Microbiology.

S. E. Reese, C. Mcevoy, R. Link-Gelles, 2023, MMWR. Morbidity and mortality weekly report.

The value of personal health records for chronic disease management: what do we know?

John Hickner, Anil Jain, Anil K. Jain, 2011, Family medicine.

Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus "Treat All" Adoption in Uganda.

J. Jarvis, Y. Manabe, A. Muganzi, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Neutralizing Antibody to Omicron BA.1, BA.2 and BA.5 in COVID-19 Patients

W. Self, N. Mohr, K. Gibbs, 2022, medRxiv.

Exposures in adult outpatients with COVID‐19 infection during early community transmission, Tennessee

Manish M Patel, W. Self, C. Lindsell, 2020, Influenza and other respiratory viruses.

Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents.

S. E. Reese, M. Stockwell, R. Link-Gelles, 2023, Pediatrics.

Coming Into Focus

M. Tenforde, S. Morris, Mark Egan, 2009 .

Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021–February 2022, VISION Network: a retrospective cohort study

R. Link-Gelles, P. Embí, K. Natarajan, 2023, Lancet regional health. Americas.

Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report—IVY Network, February 1–August 31, 2022

Akram Khan, W. Self, A. Ginde, 2023, Vaccine.

Vaccine effectiveness against influenza-associated urgent care, emergency department, and hospital encounters during the 2021-2022 season, VISION Network.

C. Mcevoy, P. Embí, B. Flannery, 2023, Journal of Infectious Diseases.

S. E. Reese, C. Mcevoy, R. Link-Gelles, 2023, MMWR. Morbidity and mortality weekly report.

Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.

S. E. Reese, C. Mcevoy, R. Link-Gelles, 2023, American Journal of Transplantation.

Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023

William F. Fadel, S. E. Reese, C. Mcevoy, 2023, MMWR. Morbidity and mortality weekly report.

Association between COVID-19 mRNA vaccination and COVID-19 illness and severity during Omicron BA.4 and BA.5 sublineage periods

William F. Fadel, S. E. Reese, C. Mcevoy, 2022, medRxiv.

HIV-associated cryptococcal meningitis: ongoing challenges and new opportunities.

J. Jarvis, M. Tenforde, 2019, The Lancet. Infectious diseases.

Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months–5 Years — VISION Network, United States, July 2022–June 2023

S. E. Reese, M. Stockwell, R. Link-Gelles, 2023, MMWR. Morbidity and mortality weekly report.

Empirical tuberculosis therapy in advanced HIV disease.

Y. Manabe, M. Tenforde, 2019, The lancet. HIV.

Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States

M. Exline, Akram Khan, W. Self, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Modulating host immune responses to fight invasive fungal infections.

J. Jarvis, J. Scriven, S. Levitz, 2017, Current opinion in microbiology.

High Mortality in HIV-Associated Cryptococcal Meningitis Patients Treated With Amphotericin B–Based Therapy Under Routine Care Conditions in Africa

J. Jarvis, M. Molefi, M. Tenforde, 2018, Open forum infectious diseases.

Digital Commons

M. Exline, A. Ginde, A. Duggal, 2022 .

Rapid antiretroviral therapy initiation in low- and middle-income countries: A resource-based approach

D. Gibb, M. Tenforde, Y. Manabe, 2019, PLoS medicine.

Digital Commons

M. Exline, A. Ginde, A. Duggal, 2022 .

Venous Thromboembolism Among People With HIV: Design, Implementation, and Findings of a Centralized Adjudication System in Clinical Care Sites Across the United States

S. Heckbert, B. Whitney, J. Keruly, 2023, Journal of acquired immune deficiency syndromes.

Vaccine Effectiveness Against SARS-CoV-2 Related Hospitalizations in People who had Experienced Homelessness or Incarceration – Findings from the Minnesota EHR Consortium

Miriam H. Muscoplat, A. Chamberlain, M. Tenforde, 2023, Journal of community health.

Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design

S. E. Reese, R. Link-Gelles, S. Grannis, 2023, Vaccine.

Interim Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza — California, October 2023–January 2024

M. Tenforde, Tomás M León, Seema Jain, 2024, MMWR. Morbidity and mortality weekly report.